Assessment of homologous and heterologous PCV2 vaccine efficacy in a PCV2d/PRRSV co-challenge model
Authors:
- Molly KroegerMKMolly Kroeger
- Eduardo FanoEFEduardo Fano
- Amanda SponheimASAmanda Sponheim
- Kent J. SchwartzKSKent J. Schwartz
- Fernando L. LeiteFLFernando L. Leite
- Oliver Gomez-DuranOGOliver Gomez-Duran
- Luiz LecznieskiLLLuiz Lecznieski
- Pablo E. PiñeyroPPPablo E. Piñeyro
Abstract
No abstract availableFunding Information
- Boehringer Ingelheim Corp USA
This publication has 24 references indexed in Scilit:
- Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2dVaccine, 2021
- Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challengeVeterinary Microbiology, 2019
- Ten years of PCV2 vaccines and vaccination: Is eradication a possibility?Veterinary Microbiology, 2017
- Revisiting the taxonomy of the family Circoviridae: establishment of the genus Cyclovirus and removal of the genus GyrovirusArchives of Virology, 2017
- Genetic diversity of porcine circovirus type 2 and implications for detection and controlResearch in Veterinary Science, 2015
- Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2)Virus Research, 2012
- Porcine circovirus type 2 and its associated diseases in ChinaVirus Research, 2012
- The analysis of 2 × 2 contingency tables—Yet againStatistics in Medicine, 2011
- Chi‐squared and Fisher–Irwin tests of two‐by‐two tables with small sample recommendationsStatistics in Medicine, 2007
- Excessive porcine circovirus type 2 antibody titres may trigger the development of porcine dermatitis and nephropathy syndrome: a case-control studyVeterinary Microbiology, 2004